In this episode, Sarah McGoldrick, Executive Director of Finance at Singing River Health System, joins the podcast to discuss evolving payer changes and their impact on the revenue cycle. She also shares insights on opportunities for growth and the introduction of GLP-1 medications and their implications for healthcare organizations.
Sarah McGoldrick, Executive Director of Finance at Singing River Health System
Advertisement
Advertisement
Next Up in Becker's Healthcare Podcast Episodes
-
In this episode, Himalee Sabnis, MD, MSc, Pediatric Hematologist and Oncologist at the Aflac Cancer and Blood Disorders Center of…
-
In this episode, Kathleen Sanford, DBA, RN, FAAN, Senior EVP, Chief Nursing Officer, CommonSpirit Health, discusses improving nurse retention through…
-
In this episode, David Marcozzi, MD, MHS-CL, Senior Vice President and Chief Clinical Officer at University of Maryland Medical Center,…
Join the 500,000+ healthcare executives who start their day with Becker's
Becker's Hospital Review Newsletter is sent Monday–Sunday.
Advertisement
Comments are closed.